The promise and harms of screening for plasma cell dyscrasias.

Mohyuddin, Ghulam Rehman; Chakraborty, Rajshekhar; Cliff, Edward R Scheffer

Mohyuddin, Ghulam Rehman; Chakraborty, Rajshekhar; Cliff, Edward R Scheffer.

Afiliação

Mohyuddin GR; Division of Hematology and Hematological Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
Chakraborty R; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York, USA.
Cliff ERS; Program on Regulation, Therapeutics and Law, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Br J Haematol ; 200(6): 704-707, 2023 03.

Article em En | MEDLINE | ID: mdl-36626939

Assuntos

Gamopatia Monoclonal de Significância Indeterminada; Mieloma Múltiplo; Paraproteinemias; Humanos

Palavras-chave

mass spectrometry; monoclonal gammopathy; multiple myeloma; plasma cell dyscrasia; screening

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Paraproteinemias / Gamopatia Monoclonal de Significância Indeterminada / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans Idioma: En Revista: Br J Haematol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google